161 related articles for article (PubMed ID: 1548521)
1. Curability of solitary bone plasmacytoma.
Dimopoulos MA; Goldstein J; Fuller L; Delasalle K; Alexanian R
J Clin Oncol; 1992 Apr; 10(4):587-90. PubMed ID: 1548521
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy in the treatment of solitary plasmacytoma.
Jyothirmayi R; Gangadharan VP; Nair MK; Rajan B
Br J Radiol; 1997 May; 70(833):511-6. PubMed ID: 9227234
[TBL] [Abstract][Full Text] [Related]
3. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1063-7. PubMed ID: 9719116
[TBL] [Abstract][Full Text] [Related]
4. Improved outcome in solitary bone plasmacytomata with combined therapy.
Avilés A; Huerta-Guzmán J; Delgado S; Fernández A; Díaz-Maqueo JC
Hematol Oncol; 1996 Sep; 14(3):111-7. PubMed ID: 9119355
[TBL] [Abstract][Full Text] [Related]
5. Solitary plasmacytoma.
Dagan R; Morris CG; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2009 Dec; 32(6):612-7. PubMed ID: 19593082
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy of solitary plasmacytoma.
Krause S; Hillengass J; Goldschmidt H; Debus J; Neuhof D
Ann Hematol; 2011 Sep; 90(9):1093-7. PubMed ID: 21336625
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years.
Barzenje DA; Kolstad A; Ghanima W; Holte H
Hematol Oncol; 2018 Feb; 36(1):217-223. PubMed ID: 28393375
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors.
Suh YG; Suh CO; Kim JS; Kim SJ; Pyun HO; Cho J
Ann Hematol; 2012 Nov; 91(11):1785-93. PubMed ID: 22752147
[TBL] [Abstract][Full Text] [Related]
9. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
Wilder RB; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Cancer; 2002 Mar; 94(5):1532-7. PubMed ID: 11920511
[TBL] [Abstract][Full Text] [Related]
10. Solitary plasmacytoma of bone and soft tissue.
Bolek TW; Marcus RB; Mendenhall NP
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):329-33. PubMed ID: 8892456
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of solitary extramedullary plasmacytoma.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Radiother Oncol; 1999 Sep; 52(3):245-9. PubMed ID: 10580871
[TBL] [Abstract][Full Text] [Related]
12. Solitary plasmacytoma of bone: treatment, progression, and survival.
Chak LY; Cox RS; Bostwick DG; Hoppe RT
J Clin Oncol; 1987 Nov; 5(11):1811-5. PubMed ID: 3681369
[TBL] [Abstract][Full Text] [Related]
13. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy in the management of solitary extramedullary plasmacytoma.
Chao MW; Gibbs P; Wirth A; Quong G; Guiney MJ; Liew KH
Intern Med J; 2005 Apr; 35(4):211-5. PubMed ID: 15836498
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoma. Treatment results and conversion to myeloma.
Holland J; Trenkner DA; Wasserman TH; Fineberg B
Cancer; 1992 Mar; 69(6):1513-7. PubMed ID: 1540888
[TBL] [Abstract][Full Text] [Related]
16. Solitary bone and extramedullary plasmacytoma.
Weber DM
Hematology Am Soc Hematol Educ Program; 2005; ():373-6. PubMed ID: 16304406
[TBL] [Abstract][Full Text] [Related]
17. Solitary plasmacytoma: experiences from Central Anatolia.
Coskun HS; Er O; Soyuer S; Altinbas M; Eser B; Karahacioglu E; Altuntas F
Ir J Med Sci; 2005; 174(1):33-6. PubMed ID: 15868887
[TBL] [Abstract][Full Text] [Related]
18. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
Tsang RW; Campbell BA; Goda JS; Kelsey CR; Kirova YM; Parikh RR; Ng AK; Ricardi U; Suh CO; Mauch PM; Specht L; Yahalom J
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):794-808. PubMed ID: 29976492
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
[TBL] [Abstract][Full Text] [Related]
20. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma.
Kilciksiz S; Karakoyun-Celik O; Agaoglu FY; Haydaroglu A
ScientificWorldJournal; 2012; 2012():895765. PubMed ID: 22654647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
